Drugs / Hydrophilic Methacrylate Gel
last change Nov 2024 re-read 3 minutes ago

Hydrophilic Methacrylate Gel

Developed for
endometriosis in cutaneous scar
Investigated by
Hamad Medical Corporation

Trials 1

PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT07547462 Dec 2023 → Oct 2024 endometriosis in cutaneous scar Hamad Medical Corporation Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Hydrophilic Methacrylate Gel ClinicalTrials.gov intervention name — accepted as the source's own label NCT07547462 ↗
Route Topical “Hydrophilic methacrylate-based hydrogel applied to cesarean section incision site” NCT07547462 ↗